Digital Health
Cadence Completes Acquisition of OpenEye Scientific
Cadence Design Systems,that it has completed the acquisition of OpenEye Scientific Software, The addition of OpenEye’s technologies and experienced…
Cadence Design Systems,that it has completed the acquisition of OpenEye Scientific Software, The addition of OpenEye’s technologies and experienced team accelerates the Cadence Intelligent System Design strategy by extending Cadence’s computational software core competency to molecular modeling and simulation that is targeted to life sciences.
Recommended AI News: ThirdEye Announces Worldwide Decentralized Augmented Reality (AR) 3D Social Network for Metaverse
OpenEye, an industry leader in computational molecular design, has pioneered physics-based approaches and the cloud-native Orion software platform to accelerate advances in human health. Its products are used by pharmaceutical and biotechnology companies for drug discovery, and its customers include 19 of the top 20 global pharmaceutical companies such as Pfizer and AstraZeneca.
Recommended AI News: Laiye Partners with Accenture to Power Intelligent Automation and Innovation at Scale
The acquisition will allow pharmaceutical and biotechnology companies to benefit from more robust drug discovery solutions that combine OpenEye’s innovative molecular modeling and simulation software solutions for drug discovery with Cadence’s algorithmic and solver expertise, efficient large data management infrastructure, and leading AI/ML and cloud solutions.
The aggregate consideration of the transaction is approximately $500 million, and the acquisition is expected to contribute immaterial revenue this year and about $40 million in fiscal year 2023.
Recommended AI News: Kemin Industries Launches Cloud-based Data Management Platform KEMINCONNECT
[To share your insights with us, please write to sghosh@martechseries.com]
The post Cadence Completes Acquisition of OpenEye Scientific appeared first on AiThority.
Keep it Short
By KIM BELLARD OK, I admit it: I’m on Facebook. I still use Twitter – whoops, I mean X. I have an Instagram account but don’t think I’ve ever posted….
Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner
The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….
Seattle startup Olamedi building platform to automate health clinic communications
A new Seattle startup led by co-founders with experience in health tech is aiming to automate communication processes for healthcare clinics with its software…
